Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory Testing, Custom Testing), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2025 - 2030

Biopharmaceuticals Manufacturing Consumables Testing Market Growth & Trends

The global biopharmaceuticals manufacturing consumables testing market size is estimated to reach USD 1.27 billion by 2030, registering a CAGR of 12.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights

  • Based on service, compendial and multi-compendial testing held the largest share, owing to demand from various manufacturers for raw materials that are compliant to regulatory standards.
  • Based on raw material, the active pharmaceutical ingredients (APIs) segment accounted for the largest revenue share, owing to the presence of a wide range of services in this segment.
  • Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2024. Rising competitive rivalry amongst market participants is also attributive for the large share of this region.
  • Asia Pacific is expected to grow at a significant CAGR over the forecast period, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Raw Material
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Business Analysis
4.1. Service Market Share, 2024 & 2030
4.2. Service Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
4.4. Laboratory Testing
4.4.1. Laboratory Testing Market, 2018 - 2030 (USD Million)
4.5. Custom Testing / Customer Proprietary Testing
4.5.1. Custom Testing / Customer Proprietary Testing Market, 2018 - 2030 (USD Million)
4.6. Compendial & Multi Compendial Laboratory Testing
4.6.1. Compendial & Multi Compendial Laboratory Testing Market, 2018 - 2030 (USD Million)
Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Business Analysis
5.1. Raw Material Market Share, 2024 & 2030
5.2. Raw Material Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Raw Material, 2018 to 2030 (USD Million)
5.4. Formulation Excipients
5.4.1. Formulation Excipients Market, 2018 - 2030 (USD Million)
5.5. Active Pharmaceutical Ingredients (API)
5.5.1. Active Pharmaceutical Ingredients (API) Market, 2018 - 2030 (USD Million)
5.6. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
5.6.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market, 2018 - 2030 (USD Million)
Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Alcami Corporation
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Merck KGaA
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Eurofins Scientific
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Agilent Technologies, Inc.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Charles River Laboratories.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Catalent, Inc
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Element Materials Technology (Avomeen Analytical Services)
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Pace Analytical Services, LLC
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings